236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1-3 June 2018

Neuromuscul Disord. 2019 Mar;29(3):251-259. doi: 10.1016/j.nmd.2019.01.002. Epub 2019 Jan 12.

236th ENMC workshop participants:
J Adachi, S F Ahmed, M C Anderton, F Broggi, N J Crabtree, I J M de Groot, P Furlong, M Guglieri, S Joseph, R Keen, J Kuijer, A Klein, M Z Mughal, E H Niks, S A Novotny, R Quinlivan, S J Roberts, U Schara, V Straub, A Stringer, F Van Ieperen, L M Ward, D R Weber, S C Wong, E Vroom, M Zacharin

¹ Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, UK. Electronic address: jarod.wong@glasgow.ac.uk.
² John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.
³ Division of Endocrinology and Metabolism, Children's Hospital of East Ontario, University of Ottawa, Ottawa, Canada.
⁴ MRC Centre for Neuromuscular Disease and Division of Neuropathology, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.

No abstract available

Publication types